Top Markets
#1 ADO Protocol ADO Protocol +193.12%
#2 Islamic Coin Islamic Coin +155.43%
#3 GoPlus Security GoPlus Security +48.69%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +17.54%
#6 Chia Chia +15.11%
#7 Casper Network Casper Network +13.73%
#8 Verus Coin Verus Coin +13.56%
#9 o1.exchange o1.exchange +12.82%
#10 Pons Pons +12.26%
Coin of the day
ADO Protocol ADO Protocol
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Antisense Therapeutics Limited Antisense Therapeutics Limited

Antisense Therapeutics Limited

ANP
Classificação em ações #33642
Antisense Therapeutics Limited, an Australian company headquartered in Toorak... Antisense Therapeutics Limited, an Australian company headquartered in Toorak and founded in 2000, specializes in the research and advancement of innovative antisense pharmaceutical drugs. Its primary pipeline asset, ATL1102, is an antisense inhibitor designed to target CD49d, which is currently in Phase II clinical trials for treating various inflammatory conditions such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. Another promising therapeutic in their portfolio is ATL1103, a second-generation antisense drug that aims to block growth hormone receptor expression, thereby lowering insulin-like growth factor-I levels in the blood, and has completed Phase II clinical trials for conditions stemming from excessive growth hormone action.
Preço da ação
$0.03702159
Última sincronização: 2024-01-29
Valor de mercado
$7.21M
Variação (1 dia)
-3.08%
Variação (1 ano)
0.00%
País
AU
Negociar Antisense Therapeutics Limited (ANP)

Categoria

Healthcare
Receita da Antisense Therapeutics Limited (ANP)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Antisense Therapeutics Limited, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Antisense Therapeutics Limited de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN